Rep. Chris Collins, the New York congressman who tirelessly promoted an Australian biotech company and who now faces charges of insider trading related to the firm, prevailed in his re-election bid on Tuesday.

Collins, who has denied the allegations, prevailed over Democrat Nathan McMurray. McMurray conceded the race late Tuesday night but called for a recall early Wednesday morning, after multiple media outlets had long since called the contest in favor of Collins.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy